Skip to Content


Genomic Medicine Program Advisory Committee

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Enhanced Content

Relevant information about this document from provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

The Department of Veterans Affairs (VA) gives notice under the Federal Advisory Committee Act, that a meeting of the Genomic Medicine Program Advisory Committee (the Committee) will be held on Wednesday, September 18, at the Hilton Garden Inn/Capitol Hill located at 1225 First Street NE, Washington, District of Columbia 20002, USA. The meeting will begin at 9 a.m. EST and adjourn at 4:30 p.m. EDT. The meeting is open to the public.

The purpose of the Committee is to provide advice and make recommendations to the Secretary of Veterans Affairs on using genetic information to optimize medical care for Veterans and to enhance development of tests and treatments for diseases particularly relevant to Veterans.

On September 18, 2019, the Committee will receive updated briefings on various VA research programs, including the Million Veteran Program (MVP) to ascertain the progress of the program in the areas of participant recruitment, data generation and storage, and data access. The Committee will also receive updates from ongoing MVP endeavors, including cohort building, data generation and usage, and the VA-Department of Energy (DOE) collaborative projects. Additionally, the Committee will discuss and explore potential recommendations to be included in the next annual report.

Public comments will be received at 3:30 p.m. and are limited to 5 minutes each. Individuals who speak are invited to submit a 1-2 page summary of their comments for inclusion in the official meeting record to Jennifer Moser, Designated Federal Officer, Office of Research and Development (10X2), 810 Vermont Avenue NW, Washington, DC 20420, or via email at In the communication, writers must identify themselves and state the organization, association or person(s) they represent. Any member of the public who wishes to attend the meeting should RSVP to Jennifer Moser at (202) 443-5678 no later than close of business, September 8, 2019 at the phone number or email address noted above.

Start Signature

Dated: August 2, 2019.

LaTonya L. Small,

Federal Advisory Committee Management Officer.

End Signature End Preamble

[FR Doc. 2019-16931 Filed 8-7-19; 8:45 am]